Related Experiment Video
Updated: Aug 12, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
[Translated article] Neurofibromatosis Type 1: Diagnostic Timelines in Children.
F J García-Martínez1, A Hernández-Martín2
1Departamento de Dermatología, Clínica Universidad de Navarra, Madrid, Spain.
Diagnosing neurofibromatosis 1 (NF1) is delayed by nearly 4 years in children without a family history. Combining skin findings may improve early NF1 diagnosis in pediatric patients.
Area of Science:
- Genetics
- Pediatric Medicine
- Dermatology
Background:
- Diagnosing neurofibromatosis 1 (NF1) presents challenges in young children, particularly those without a known family history.
- Early and accurate diagnosis is crucial for timely management and intervention.
Purpose of the Study:
- To determine the diagnostic delay for NF1 in children lacking a family history.
- To evaluate the impact of considering café-au-lait macules and skinfold freckling as a unified diagnostic criterion.
Main Methods:
- A retrospective, descriptive, observational study was conducted on 108 pediatric patients diagnosed with NF1.
- Medical records were reviewed to pinpoint the time diagnostic criteria were met.
- Patients were grouped based on the presence or absence of a parental NF1 history.
Main Results:
- The average age of NF1 diagnosis was 3.94 years overall.
- Patients without a family history experienced an average diagnostic delay of 3 years and 8 months, with diagnosis at 4 years and 8 months.
- Patients with a known parental history were diagnosed significantly earlier, around 1 year of age.
Conclusions:
- Skin manifestations, such as café-au-lait macules and freckling, are often the initial signs of NF1.
- Updating the National Institutes of Health diagnostic criteria for NF1 may enhance early detection in pediatric populations.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024